A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Participants Followed by a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study in Participants with Moderate-To-Severe Active Ulcerative Colitis.
Datos básicos
Documentos
- No hay documentos
Grupos
Financiadores - Promotores
XENCOR, INC.
Cita
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Participants Followed by a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study in Participants with Moderate-To-Severe Active Ulcerative Colitis. (XmAb942-01). XENCOR, INC. 2026IP:MARIAM AGUAS PERIS.
Portal de investigación